Blood Glucose
2-year continuous monitoring from Dexcom G7
Blood Glucose
Dexcom G7. Sensor: 8 days remaining. Last reading: 2 min ago
Diabetes Management Profile
Diagnosis
Type 2
Since 2022
HbA1c
5.4%
Normal (was 6.1%)
Medication
Metformin
500mg 2x daily
Management
Excellent
92% time in range
Paul was diagnosed with Type 2 diabetes in 2022 with an HbA1c of 6.8%. Through the VLC program, consistent walking, dietary changes, and CGM monitoring, his HbA1c has dropped to 5.4%, now in the normal range. His endocrinologist is considering reducing his Metformin dosage at the next visit.
Alert Thresholds
Urgent Low
Immediate alert + emergency contact notification
Low
Alert to Paul + care team notification
Target Range
No alerts, optimal zone
High
Alert after 30 min sustained above threshold
Urgent High
Immediate alert + care team notification
Alerts are sent to: Paul (in-app + push), Sarah Demo (SMS), Care Team (dashboard)
94
Current
93
Today Avg
92%
Time in Range
19%
Variability CV
24-Hour Glucose
Click for 7-day viewWeekly Averages
Click for detailsTime in Range
24-Month Trend
108 mg/dL → 93 mg/dL
HbA1c Correlation
Current HbA1c
5.4%
Normal range
Program Start HbA1c
6.1%
Pre-diabetic
Diabetes Management Insight
Paul's Type 2 diabetes is exceptionally well-managed. His average glucose of 93 mg/dL and HbA1c of 5.4% are now in the normal range, down from pre-diabetic levels (6.1%) when he joined VLC. Time in range of 92% far exceeds the clinical target of 70%. Nighttime lows have been reduced from ~2/month to 1/month through bedtime snack adjustments. His endocrinologist is considering reducing Metformin at the next visit.
This simulates what happens when Paul's CGM detects a reading below 70 mg/dL, alerts go to Paul, his daughter Sarah, and the care team simultaneously.